期刊文献+

哌拉西林钠舒巴坦钠持续静滴治疗重症肺炎的疗效观察 被引量:8

Clinical observation of piperacillin and sulbactam sodium continuous iv drip in treatment of severe pneumonia
原文传递
导出
摘要 目的探讨哌拉西林钠舒巴坦钠持续静滴治疗重症肺炎的临床疗效和安全性。方法选取2012年6月—2014年2月内蒙古林业总医院收治的重症肺炎90例,随机分为治疗组(46例)和对照组(44例)。治疗组患者首先给予注射用哌拉西林钠舒巴坦钠5.0 g溶入到200 m L生理盐水中,1 h内静滴完,然后将注射用哌拉西林钠舒巴坦钠5.0 g溶入至20 m L生理盐水中,将微量泵泵入速度调整为2 m L/h持续泵入,2次/d。对照组静脉滴注注射用哌拉西林钠舒巴坦钠5.0 g溶入至200m L生理盐水中,1 h静滴完,每8小时一次。两组均持续治疗3 d以上。比较两组的临床疗效,同时比较两组咳嗽消失时间、啰音消失时间、体温恢复正常时间、白细胞恢复正常时间。结果治疗后,治疗组和对照组的总有效率分别为80.44%、59.09%,两组总有效率比较差异有统计学意义(P<0.05)。治疗组咳嗽消失时间、啰音消失时间、体温恢复正常时间、白细胞恢复正常时间均显著短于对照组,两组比较差异有统计学意义(P<0.05)。结论哌拉西林钠舒巴坦钠持续静滴对重症肺炎有较好的临床疗效,可缩短各观察指标的时间,值得临床推广应用。 Objective To investigate the clinical effect of piperacillin and sulbactam sodium continuous iv drip in treatment of severe pneumonia. Methods Patients(90 cases) with severe pneumonia from June 2012 to February 2014 in the Inner Mongolia Forestry General Hospital were randomly divided into treatment(46 cases) and control(44 cases) groups. The patients in the treatment group were iv administered with Piperacillin and Sulbactam Sodium for injection 5.0 g adding into 200 m L 0.9% saline solution in 1 h, then diluted with 20 m L physiological saline continuous iv pump infusion, and the pumping speed was adjusted at 2 m L/h, twice daily. The patients in the control group were iv administered with Piperacillin and Sulbactam Sodium for injection 5.0 g adding into 200 m L 0.9% saline solution in 1 h, every 8 h/time. The patients in the two groups were treated for more than 3 d. After the treatment, the efficacy was evaluated, while the time of cough disappeared, rale disappear time, body temperature returned to normal time, and white blood cells back to normal time in two groups were compared. Results The efficacies in the treatment and control groups were 80.44% and 59.09%, respectively, and there were differences between two groups(P〈0.05). The time of cough disappeared, rale disappear time, body temperature returned to normal time, and white blood cells back to normal time in treatment group were shorter than those in the control group, and there were differences between two groups(P〈0.05). Conclusion Piperacillin and sulbactam sodium continuous iv drip has good clinical effect in treatment of severe pneumonia, and can shorten the time of observational indexes, which is worth of clinical promotion.
出处 《现代药物与临床》 CAS 2014年第12期1396-1398,共3页 Drugs & Clinic
关键词 哌拉西林钠舒巴坦钠 重症肺炎 持续静滴 Piperacillin and Sulbactam Sodium for injection severe pneumonia continuous iv drip
  • 相关文献

参考文献4

二级参考文献12

共引文献95

同被引文献86

  • 1肖政辉,易著文,胥志跃,罗海燕,祝益民.重症肺炎患儿血浆IL-1、IL-6、IL-8、TNF-α变化及临床意义[J].医学临床研究,2007,24(8):1345-1346. 被引量:25
  • 2Pereyre S, Charron A, Renaudin H, et al. First report of macrolide resist- ant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in mycoplasma pneumoniae clinical strains isolated in France over 12 years[ J]. J Clip Microbiol,2007,45 ( 11 ) :3534 - 3539.
  • 3Morar M, Pengetly K, Koteva K, et al. Mechanism and diversity of the e- rythmmyein esterase family of enzymes [ J ]. Biochemistry,2012,51 ( 8 ) : 1740 - 1751.
  • 4American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancerl, Cooper DS, Doherty GM, et aL Revised American Thyroid Association management guidelines for pa- tients with thyroid nodules and differentiated thyroid cancer [ J ]. Thy- roid,2009,19 ( 11 ):t 167 - 1214.
  • 5Peuchant 01, Maard A, Renaudin H, et al. Increased macrolide resist- ance of Mycoplasma pneumoniae in France directly detected in clinical specimens by reai- time PCR and melting eurveanalysis[J]. J Antimi- crab Chemother,2009,64 ( 1 ) 152 - 581.
  • 6Atkinson riP, Balish MF, Waites KB, et al. Epidemiology, clinical mani- festations, pathogenesis and laboratory detection of Myeoplasma pneu- moniae infections[ J ]. FEMS Micmbiol Rev,2008,32 (6) :956 - 973.
  • 7梁志科,刘朝晖.呼吸机相关性肺炎预防研究进展[J].中华医院感染学杂志,2008,18(1):148-150. 被引量:112
  • 8Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after isehemic stroke[J]. Neu- rology, 2011, 77 (14) : 1338-1345.
  • 9王钢,黄润忠.新生儿肺炎致病菌药敏试验及临床分析[J].中国煤炭工业医学杂志,2009,12(3):369-370. 被引量:1
  • 10肖靖华.哌拉西林/舒巴坦治疗老年重症肺炎的疗效和安全性评价[J].临床肺科杂志,2010,15(2):168-169. 被引量:5

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部